Naganuma A
Department of Molecular and Biochemical Toxicology, Faculty of Pharmaceutical Sciences, Tohoku University.
Nihon Rinsho. 1997 May;55(5):1091-5.
Metallothionein is a low-molecular weight protein involved in resistance to toxicity of heavy metals. Recent experimental evidences indicate that metallothionein appears to be a factor in determining the responsiveness of tumor cells to anticancer drugs, such as cisplatin and adriamycin. The resistance of tumor cells having high concentration of metallothionein to cisplatin has been observed in cultured cells and transplanted tumors. On the other hand, increase in metallothionein concentration in normal tissues of tumor-bearing animals prevents side effects of anticancer drugs. Metallothionein may be an important endogenous factor in cancer chemotherapy.
金属硫蛋白是一种参与抵抗重金属毒性的低分子量蛋白质。最近的实验证据表明,金属硫蛋白似乎是决定肿瘤细胞对顺铂和阿霉素等抗癌药物反应性的一个因素。在培养细胞和移植肿瘤中已观察到金属硫蛋白浓度高的肿瘤细胞对顺铂具有抗性。另一方面,荷瘤动物正常组织中金属硫蛋白浓度的增加可预防抗癌药物的副作用。金属硫蛋白可能是癌症化疗中的一个重要内源性因素。